Adagio raises a monster $336M round for bespoke COVID-19 drug battle

Retrieved on: 2021-04-19 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Adagio raises a monster $336M round for bespoke COVID-19 drug battle. View article details on hiswai:

Excerpt

It may be zeroing in on SARS-CoV-2—the virus that causes COVID-19—but ADG20 and Adagio's other antibodies are designed to protect against other ...

Article found on: www.fiercebiotech.com